DHODH and neuroblastoma: Moreover, in SK-N-AS cells (high MES score, Supplemental Figure 3E), we observed a plateau effect where increasing doses of brequinar did not further decrease cell viability (Supplemental Figure 2A), suggesting that neuroblastoma cells with a predominantly MES phenotype are less dependent on DHODH and more resistant to its inhibition.